Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.
Aspen Aerogels Stock Performance
Shares of NYSE:ASPN opened at $13.60 on Friday. The company has a current ratio of 3.00, a quick ratio of 2.76 and a debt-to-equity ratio of 0.62. Aspen Aerogels has a 1-year low of $7.93 and a 1-year high of $65.99. The stock has a market capitalization of $550.00 million, a P/E ratio of -6.77 and a beta of 2.22. The business has a 50-day moving average price of $13.27 and a two-hundred day moving average price of $21.69.
Aspen Aerogels (NYSE:ASPN - Get Rating) last posted its quarterly earnings results on Wednesday, July 27th. The construction company reported ($0.68) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by ($0.12). Aspen Aerogels had a negative return on equity of 46.30% and a negative net margin of 46.41%. During the same quarter in the prior year, the company earned ($0.23) EPS. Equities analysts predict that Aspen Aerogels will post -2.19 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on ASPN. Cowen increased their price objective on Aspen Aerogels to $72.00 in a research note on Thursday, June 9th. Benchmark reduced their price target on shares of Aspen Aerogels to $29.00 in a research report on Tuesday. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $47.00 to $32.00 and set a "buy" rating for the company in a report on Tuesday, May 3rd. B. Riley reduced their target price on Aspen Aerogels from $44.00 to $34.00 in a report on Wednesday, July 27th. Finally, Craig Hallum dropped their price target on Aspen Aerogels from $50.00 to $32.00 and set a "buy" rating for the company in a report on Thursday, July 7th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of "Buy" and an average target price of $48.20.